High-Throughput Sequencing of Circulating MicroRNAs in Plasma and Serum during Pregnancy Progression
Authors:
- Elena S. VashukovaEVElena S. Vashukova
- Polina Y. KozyulinaPKPolina Y. Kozyulina
- Roman A. IllarionovRIRoman A. Illarionov
- Natalya O. YurkinaNYNatalya O. Yurkina
- Olga V. PachuliiaOPOlga V. Pachuliia
- Mariya G. ButenkoMBMariya G. Butenko
- Tatyana B. PostnikovaTPTatyana B. Postnikova
- Lada A. IvanovaLILada A. Ivanova
- Dina R. EremeevaDEDina R. Eremeeva
- Marina S. ZainulinaMZMarina S. Zainulina
- Olesya N. BespalovaOBOlesya N. Bespalova
- Andrey S. GlotovAndrey S. Glotov
Open Access
Abstract
Although circulating microRNAs (miRNAs) in maternal blood may play an important role in regulation of pregnancy progression and serve as non-invasive biomarkers for different gestation complications, little is known about their profile in blood during normally developing pregnancy. In this study we evaluated the miRNA profiles in paired plasma and serum samples from pregnant women without health or gestational abnormalities at three time points using high-throughput sequencing technology. Sequencing revealed that the percentage of miRNA reads in plasma and serum decreased by a third compared to first and second trimesters. We found two miRNAs in plasma (hsa-miR-7853-5p and hsa-miR-200c-3p) and 10 miRNAs in serum (hsa-miR-203a-5p, hsa-miR-495-3p, hsa-miR-4435, hsa-miR-340-5p, hsa-miR-4417, hsa-miR-1266-5p, hsa-miR-4494, hsa-miR-134-3p, hsa-miR-5008-5p, and hsa-miR-6756-5p), that exhibit level changes during pregnancy (p-value adjusted < 0.05). In addition, we observed differences for 36 miRNAs between plasma and serum (p-value adjusted < 0.05), which should be taken into consideration when comparing the results between studies performed using different biosample types. The results were verified by analysis of three miRNAs using qRT-PCR (p < 0.05). The present study confirms that the circulating miRNA profile in blood changes during gestation. Our results set the basis for further investigation of molecular mechanisms, involved in regulation of pregnancy, and the search for biomarkers of gestation abnormalities.Keywords
Funding Information
- Russian Science Foundation (19-75-20033)
- D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproductology (АААА-А19119021290033-1)
This publication has 44 references indexed in Scilit:
- Circulating MicroRNAs as Novel Biomarkers for Platelet ActivationCirculation Research, 2013
- Comparing the MicroRNA Spectrum between Serum and PlasmaPLOS ONE, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Placental microRNA expression in pregnancies complicated by preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2011
- Expression Profile of MicroRNAs and mRNAs in Human Placentas From Pregnancies Complicated by Preeclampsia and Preterm LaborReproductive Sciences, 2011
- Circulating microRNAs are new and sensitive biomarkers of myocardial infarctionEuropean Heart Journal, 2010
- Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humansEuropean Heart Journal, 2010
- Serum MicroRNAs Are Promising Novel BiomarkersPLOS ONE, 2008
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008